Computational studies to predict or explain G protein coupled receptor polypharmacology

Trends in Pharmacological Sciences

Volumn 35, Issue 12, 2014, Pages 658-663

  Jacobson, Kenneth A ^a   Costanzi, Stefano ^b   Paoletta, Silvia ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b AMERICAN UNIVERSITY   (United States)

Author keywords

bioinformatics; chemoinformatics; G protein coupled receptors; molecular modeling

Indexed keywords

1,4 DIHYDROPYRIDINE; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE A3 RECEPTOR ANTAGONIST; ADENOSINE DERIVATIVE; ANTIASTHMATIC AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; ANTINOCICEPTIVE AGENT; ASPARTIC ACID; BIOGENIC AMINE; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CLOZAPINE; COUNTERION; DOPAMINE 2 RECEPTOR BLOCKING AGENT; DOPAMINE 3 RECEPTOR BLOCKING AGENT; G PROTEIN COUPLED RECEPTOR; HYDROGEN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR STIMULATING AGENT; NEUROLEPTIC AGENT; NIFEDIPINE; RECEPTOR; SEROTONIN 1A AGONIST;

BINDING AFFINITY; BIOINFORMATICS; CHANNEL GATING; CHEMOINFORMATICS; CRYSTAL STRUCTURE; DRUG DESIGN; DRUG RESEARCH; DRUG SCREENING; DRUG STRUCTURE; DRUG TARGETING; HUMAN; HYDROGEN BOND; LIGAND BINDING; MATHEMATICAL COMPUTING; MEDICAL INFORMATICS; MOLECULAR DOCKING; MOLECULAR DYNAMICS; MOLECULAR MODEL; MOLECULAR RECOGNITION; POLYPHARMACOLOGY; PREDICTION; PROTEIN CONFORMATION; PROTEIN FAMILY; PROTEIN STRUCTURE; RECEPTOR BINDING; RECEPTOR UPREGULATION; REVIEW; STRUCTURE ACTIVITY RELATION; X RAY CRYSTALLOGRAPHY; BIOLOGY; CHEMISTRY; METABOLISM; MOLECULARLY TARGETED THERAPY;

COMPUTATIONAL BIOLOGY; CRYSTALLOGRAPHY, X-RAY; DRUG DESIGN; HUMANS; MOLECULAR TARGETED THERAPY; POLYPHARMACOLOGY; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84913587112     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2014.10.009     Document Type: Review

References (59)

1. N.H. Jensen, and B.L. Roth Massively parallel screening of the receptorome Comb. Chem. High Throughput Screen. 6 2008 420 426
2. A. Anighoro Polypharmacology: challenges and opportunities in drug discovery J. Med. Chem. 57 2014 7874 7887
3. J.U. Peters Polypharmacology - foe or friend? J. Med. Chem. 56 2013 8955 8971
4. M.J. Keiser Predicting new molecular targets for known drugs Nature 462 2009 175 181
5. D. Gloriam The G protein-coupled receptor subset of the rat genome BMC Genomics 8 2007 338
6. M. Congreve, and F. Marshall The impact of GPCR structures on pharmacology and structure-based drug design Br. J. Pharmacol. 159 2010 986 996
7. S. Costanzi, and K. Wang The GPCR crystallography boom: providing an invaluable source of structural information and expanding the scope of homology modeling Adv. Exp. Med. Biol. 796 2014 3 13
8. K.A. Jacobson, and S. Costanzi New insights for drug design from the X-ray crystallographic structures of G-protein-coupled receptors Mol. Pharmacol. 82 2012 361 371
9. D. Rognan Novel chemogenomic approaches to drug design A. Darvas, Chemical Genomics and Proteomics 2nd edn 2013 CRC Press 173 204
10. S. Costanzi Modeling G protein-coupled receptors and their interactions with ligands Curr. Opin. Struct. Biol. 23 2013 185 190
11. S. Costanzi Homology modeling of class a g protein-coupled receptors Methods Mol. Biol. 857 2012 259 279
12. S. Costanzi Modelling G protein-coupled receptors: a concrete possibility Chim. Oggi 28 2010 26 30
13. M. Michino Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008 Nat. Rev. Drug Discov. 8 2009 455 463
14. I. Kufareva Status of GPCR modeling and docking as reflected by community-wide GPCR Dock 2010 assessment Structure 19 2011 1108 1126
15. V. Katritch, and R. Abagyan GPCR agonist binding revealed by modeling and crystallography Trends Pharmacol. Sci. 32 2011 637 643
16. S. Costanzi On the applicability of GPCR homology models to computer-aided drug discovery: a comparison between in silico and crystal structures of the beta2-adrenergic receptor J. Med. Chem. 51 2008 2907 2914
17. Y.Y. Li A computational approach to finding novel targets for existing drugs PLoS Comput. Biol. 7 2011 e1002139
18. S. Costanzi, and S. Vilar In silico screening for agonists and blockers of the β2 adrenergic receptor: implications of inactive and activated state structures J. Comput. Chem. 33 2012 561 572
19. S. Vilar, and S. Costanzi Predicting the biological activities through QSAR analysis and docking-based scoring Methods Mol. Biol. 914 2012 271 284
20. S. Vilar Docking-based virtual screening for ligands of G protein-coupled receptors: not only crystal structures but also in silico models J. Mol. Graph. Model. 29 2011 614 623
21. S. Costanzi Chapter 18 Structure-based virtual screening for ligands of g protein-coupled receptors J. Giraldo, J-P. Pin, G Protein-Coupled Receptors: From Structure to Function 2011 The Royal Society of Chemistry 359 374
22. D.R. Weiss Conformation guides molecular efficacy in docking screens of activated beta-2 adrenergic G protein coupled receptor ACS Chem. Biol. 8 2013 1018 1026
23. M.M. Mysinger Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4 Proc. Natl. Acad. Sci. U.S.A. 109 2012 5517 5522
24. B.K. Shoichet, and B.K. Kobilka Structure-based drug screening for G-protein-coupled receptors Trends Pharmacol. Sci. 33 2012 268 272
25. J. Carlsson Ligand discovery from a dopamine D3 receptor homology model and crystal structure Nat. Chem. Biol. 7 2011 769 778
26. A. Schlessinger Structure-based discovery of prescription drugs that interact with the norepinephrine transporter, NET Proc. Natl. Acad. Sci. U.S.A. 108 2011 15810 15815
27. J. Carlsson Structure-based discovery of A2A adenosine receptor ligands J. Med. Chem. 53 2010 3748 3755
28. J.R. Lane Structure-based ligand discovery targeting orthosteric and allosteric pockets of dopamine receptors Mol. Pharmacol. 84 2013 794 807
29. V. Katritch Structure-based discovery of novel chemotypes for adenosine A2A receptor antagonists J. Med. Chem. 53 2010 1799 1809
30. M. Gabrielsen Identification of novel serotonin transporter compounds by virtual screening J. Chem. Inf. Model. 54 2014 933 943
31. C. de Graaf Crystal structure-based virtual screening for fragment-like ligands of the human histamine H1 receptor J. Med. Chem. 54 2011 8195 8206
32. V. Katritch GPCR 3D homology models for ligand screening: lessons learned from blind predictions of adenosine A2A receptor complex Proteins 78 2010 197 211
33. I. Tikhonova Discovery of novel agonists and antagonists of the free fatty acid receptor 1 (FFAR1) using virtual screening J. Med. Chem. 51 2008 625 633
34. S. Engel A virtual screen for diverse ligands: discovery of selective G protein-coupled receptor antagonists J. Am. Chem. Soc. 130 2008 5115 5123
35. M.M. Mysinger Structure-based ligand discovery for the protein-protein interface of chemokine receptor CXCR4 Proc. Natl. Acad. Sci. U.S.A. 109 2012 5517 5522
36. S. Paoletta Structural probing of off-target G protein-coupled receptor activities within a series of adenosine/adenine congeners PLoS ONE 9 2014 e97858 10.1371/journal.pone.0097858
37. A. Krishnan The origin of GPCRs: identification of mammalian like rhodopsin, adhesion, glutamate and frizzled GPCRs in fungi PLoS ONE 7 2012 e29817
38. T. Haitina The G protein-coupled receptor subset of the dog genome is more similar to that in humans than rodents BMC Genomics 10 2009 24
39. J. Surgand A chemogenomic analysis of the transmembrane binding cavity of human G-protein-coupled receptors Proteins 62 2006 509 538
40. R. Fredriksson, and H. Schiöth The repertoire of G-protein-coupled receptors in fully sequenced genomes Mol. Pharmacol. 67 2005 1414 1425
41. R. Fredriksson The G-protein-coupled receptors in the human genome form five main families. Phylogenetic analysis, paralogon groups, and fingerprints Mol. Pharmacol. 63 2003 1256 1272
42. J. Hu A missense mutation in the seven-transmembrane domain of the human Ca2+ receptor converts a negative allosteric modulator into a positive allosteric modulator J. Biol. Chem. 281 2006 21558 21565
43. H. Kleinau Signaling-sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor FASEB J. 24 2010 2347 2354
44. A. Doré Structure of class C GPCR metabotropic glutamate receptor 5 transmembrane domain Nature 511 2014 557 562
45. J. Hert Quantifying the relationships among drug classes J. Chem. Inf. Model. 48 2008 755 765
46. J.S. Mason High end GPCR design: crafted ligand design and druggability analysis using protein structure, lipophilic hotspots and explicit water networks In Silico Pharmacol 1 2013 23 10.1186/2193-9616-1-23
47. D. Sabbadin, and S. Moro Supervised molecular dynamics (SuMD) as a helpful tool to depict GPCR-ligand recognition pathway in a nanosecond time scale J. Chem. Inf. Model. 54 2014 372 376
48. A.J. Venkatakrishnan Molecular signatures of G-protein-coupled receptors Nature 494 2013 185 194
49. J.A. Ballesteros, and H. Weinstein Integrated methods for the construction of three-dimensional models of structure-function relations in G protein-coupled receptors Methods Neurosci. 25 1995 366 428
50. J. Mestres, and E. Gregori-Puigjané Conciliating binding efficiency and polypharmacology Trends Pharmacol. Sci. 30 2009 470 474
51. D. Triggle 1,4-Dihydropyridines as calcium channel ligands and privileged structures Cell. Mol. Neurobiol. 23 2003 293 303
52. J.L. Jiang Structure activity relationships of 4-phenylethynyl-6-phenyl-1,4-dihydropyridines as highly selective A3 adenosine receptor antagonists J. Med. Chem. 40 1997 2596 2608
53. H. Sun Classification of scaffold-hopping approaches Drug Discov. Today 17 2012 310 324
54. G.A. Ross One size does not fit all: the limits of structure-based models in drug discovery J. Chem. Theor. Comput. 9 2013 4266 4274
55. P.M. Petrone Rethinking molecular similarity: comparing compounds on the basis of biological activity ACS Chem. Biol. 7 2012 1399 1409
56. A.M. Wassermann A screening pattern recognition method finds new and divergent targets for drugs and natural products ACS Chem. Biol. 9 2014 1622 1631 Published online June 2, 2014 10.1021/cb5001839
57. K. Palczewski, and T. Orban From atomic structures to neuronal functions of G protein-coupled receptors Ann. Rev. Neurosci. 36 2013 139 164
58. S. Costanzi Rhodopsin and the others: a historical perspective on structural studies of G protein-coupled receptors Curr. Pharm. Des. 15 2009 3994 4002
59. C. Laggner Chemical informatics and target identification in a zebrafish phenotypic screen Nat. Chem. Biol. 8 2011 144 146